000 01257 a2200361 4500
005 20250515091202.0
264 0 _c20080220
008 200802s 0 0 eng d
022 _a0969-8051
024 7 _a10.1016/j.nucmedbio.2007.03.010
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKung, Hank F
245 0 0 _aClinical acceptance of a molecular imaging agent: a long march with [99mTc]TRODAT.
_h[electronic resource]
260 _bNuclear medicine and biology
_cOct 2007
300 _a787-9 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aBrain
_xdiagnostic imaging
650 0 4 _aHumans
650 0 4 _aMolecular Probe Techniques
_xtrends
650 0 4 _aOrganotechnetium Compounds
650 0 4 _aParkinson Disease
_xdiagnostic imaging
650 0 4 _aPractice Patterns, Physicians'
_xtrends
650 0 4 _aRadionuclide Imaging
650 0 4 _aRadiopharmaceuticals
650 0 4 _aTaiwan
650 0 4 _aTropanes
700 1 _aKung, Mei-Ping
700 1 _aWey, Shiaw-Pyng
700 1 _aLin, Kun-Ju
700 1 _aYen, Tzu-Chen
773 0 _tNuclear medicine and biology
_gvol. 34
_gno. 7
_gp. 787-9
856 4 0 _uhttps://doi.org/10.1016/j.nucmedbio.2007.03.010
_zAvailable from publisher's website
999 _c17442319
_d17442319